The story of Viagra, and its creator copyright, presents a complex case study for investors. At first a blockbuster drug, generating billions in sales , its exclusivity period created a deluge of generic competition , significantly eroding its dominance. While specific businesses may attempt to capitalize on related treatments , the current landsca